• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number H74939295701510
Device Problems Stretched (1601); Activation, Positioning or Separation Problem (2906)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 10/04/2017
Event Type  malfunction  
Manufacturer Narrative
(b)(4).Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that partial stent deployment and stent elongation occurred.The greater than 70% stenosed, moderately calcified, and moderately tortuous target lesion was located in the superficial femoral artery (sfa).Following pre-dilation, a 7 x 150 x 130 eluvia¿ drug-eluting vascular stent system was advanced anterograde over a.035 terumo guidewire and stent deployment was initiated.After approximately 50% of the stent being deployed, the thumbwheel blocked and was no longer working.The pull grip was used to deploy the stent; however force was required to deploy the stent resulting in the implanted stent being elongated.There were no patient complications and there was no issue/consequence for the patient.
 
Manufacturer Narrative
Updated: event date, describe event or problem, if implanted, give date, if remedial action, type, 21 usc 360i(f) number.Bsc id (b)(4).
 
Event Description
It was further reported that the stent stretched to 220 mm and covered an important collateral branch.No further action was taken to the elongated stent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6988945
MDR Text Key91207938
Report Number2134265-2017-10466
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Remedial Action Recall
Type of Report Initial,Followup
Report Date 10/09/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/26/2018
Device Model NumberH74939295701510
Device Catalogue Number39295-70151
Device Lot Number0020742397
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/09/2017
Initial Date FDA Received10/30/2017
Supplement Dates Manufacturer Received11/02/2017
Supplement Dates FDA Received11/28/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/15/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Removal/Correction Number92169170-FA
Patient Sequence Number1
-
-